## CPAY: Corpay, Inc. - XLK: Technology

### Executive Summary

No clear thesis: MRS_10 at 3.7%, does not meet entry criteria. Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($295.74)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-05 | Oppenheimer | $380 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-05 | Oppenheimer | up | Outperform |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 60.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- JPMORGAN CHASE & CO: 12.7% (+93.8%)
- Vanguard Group Inc: 11.7% (+0.7%)
- Blackrock Inc.: 9.0% (+0.3%)
- Orbis Allan Gray Ltd: 5.9% (+7.1%)
- Price (T.Rowe) Assoc: 5.5% (-21.3%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Momentum building: MRS_10 improving +3.8% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.92 indicates undervaluation relative to growth. Forward P/E 12.6x attractive for 17% earnings growth. Quality metrics strong (ROE 29%, margin 24%). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $22.0B |
| Beta | 0.85 |
| 52W Range | $252.84 - $400.81 |
| Short Interest | 2.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.92 |
| Forward P/E | 12.6 |
| Current P/E | 14.7 |
| YoY Growth | 16.9% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -0.1% to 3.7% (+3.8% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (3.0-6.0%), cross-sectional ranking at 70th percentile. MRS_5 at 1.8% confirms short-term momentum alignment. Outperforming sector by 4.1pp, stock-specific strength. Below SMA200 (0.99x), long-term trend not supportive. MACD histogram positive (2.01), confirming momentum. OFD pattern: -MLN (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 3.67% (CS: 70) | Strong |
| RSI_14 | 63.1 | Neutral |
| MACD Histogram | 2.01 | Bullish |
| vs SMA20 | 1.055x | Above |
| vs SMA50 | 1.090x | Above |
| vs SMA200 | 0.990x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $312.16
- **Stop Loss:** $295.74 (5.3% risk)
- **Target:** $328.58 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 60
- **Position Value:** $18,729.60
- **Portfolio %:** 18.73%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at moderate levels (16.5) with elevated put/call ratio suggesting cautious positioning, while normal yield curve and stable breadth indicate no systemic stress. Focus on selective opportunities with defensive positioning.*

### Earnings

**Next:** 2026-02-04 (Est: $5.93)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $5.64 | $5.70 | +1.0% |
| 2025Q2 | $5.12 | $5.13 | +0.1% |
| 2025Q1 | $4.51 | $4.51 | -0.1% |
| 2024Q4 | $5.35 | $5.36 | +0.2% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*